Neonatal Hyperbilirubinemia: 
Etiology, Symptoms 
and Management


M. Terese Verklan, PhD, CCNS, RNC, FAAN

Neonatal Clinical Nurse Specialist



Neonatal hyperbilirubinemia is benign in healthy infants, but can be a significant clinical condition in high-risk babies. An understanding of the pathophysiology, etiologies and management is essential for the nurse when caring for neonates. This CE activity will discuss the physiology, pathophysiology, etiologies, clinical signs and symptoms and therapeutic management of neonates with conjugated/unconjugated bilirubin.


After review of the module, the participant will be able to:

  1. Discuss the physiology and pathophysiology of   hyperbilirubinemia

  2. Identify etiologies of neonatal hyperbilirubinemia

  3. Evaluate treatment strategies, including phototherapy, for the neonate with hyperbilirubinemia


Please register to watch the webinar. Once you have completed viewing the webinar, you will able to log onto and complete the evaluation and post-test to receive your CE certificate of completion

Supported by an educational grant 

Philips Healthcare

Continuing Education for Nurses and Respiratory Therapists 

This program has been approved for 1.0 contact hour. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477
and the Florida Board of Nursing Provider # 50-17032